About Tesalys
Tesalys is a company based in Toulouse (France) founded in 2012 by Miquel Lozano and Jean-Michel Rodriguez. Tesalys has raised $8.2 million across 2 funding rounds from investors including IXO, Sigma Gestion and Entrepreneur Venture. Tesalys offers products and services including STERIPLUS™, STERISHRED®, and Tesatruck. Tesalys operates in a competitive market with competitors including RxDestruct, Biotic Waste, Sterilissolutions, Alexander International Innovations and Rotoblock, among others.
- Headquarter Toulouse, France
- Founders Miquel Lozano, Jean-Michel Rodriguez
-
Sectors
Environment
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.2 M (USD)
in 2 rounds
-
Latest Funding Round
$6.84 M (USD), Series A
Jan 28, 2019
-
Investors
IXO
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tesalys
Tesalys offers a comprehensive portfolio of products and services, including STERIPLUS™, STERISHRED®, and Tesatruck.
Grinds and disinfects infectious waste using steam sterilization technology.
Shreds and decontaminates medical waste for safe disposal.
Provides mobile system for on-site infectious waste treatment.
People of Tesalys
Unlock access to complete
Unlock access to complete
Funding Insights of Tesalys
Tesalys has successfully raised a total of $8.2M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.84 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $6.8M
-
First Round
First Round
(07 Jul 2014)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Series A - Tesalys | Valuation | IXO , Sigma Gestion |
|
| Jul, 2014 | Amount | Series A - Tesalys | Valuation |
investors |
Investors in Tesalys
Tesalys has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include IXO, Sigma Gestion and Entrepreneur Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in France are managed by IXO.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tesalys
Financial Statements - Tesalys
Tesalys Comparisons
Competitors of Tesalys
Tesalys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RxDestruct, Biotic Waste, Sterilissolutions, Alexander International Innovations and Rotoblock, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Opioid medical waste is destroyed for healthcare facilities.
|
|
| domain | founded_year | HQ Location |
Provides biomedical waste collection, treatment, and disposal services for facilities.
|
|
| domain | founded_year | HQ Location |
On-site medical waste is converted to harmless material for disposal.
|
|
| domain | founded_year | HQ Location |
Medical devices for waste disposal in plasma-derived medications are developed.
|
|
| domain | founded_year | HQ Location |
Bio-hazardous waste incinerators are manufactured using heat, pressure, and steam.
|
Latest news on Tesalys
Frequently Asked Questions about Tesalys
Tesalys was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Tesalys is headquartered in Toulouse, France. It is registered at Toulouse, Occitanie, France.
Tesalys is a funded company, having raised a total of $8.2M across 2 funding rounds to date. The company's 1st funding round was a Series A of $1.36M, raised on Jul 07, 2014.
Treatment solutions for infectious medical waste. It provides solutions to decontaminate bio-medical infectious waste using steam.
Tesalys's top competitors include RxDestruct, Rotoblock and Alexander International Innovations.
Tesalys offers STERIPLUS™, STERISHRED®, and Tesatruck.
Tesalys has 3 investors. Key investors include IXO, Sigma Gestion, and Entrepreneur Venture.